A robust growth strategy is important for a fast developing specialty biopharmaceutical company. Through strategic in-licensing and productive academic collaborations, ObsEva is building a portfolio of products and product candidates for women’s reproductive health that can address significant unmet medical needs for millions of women worldwide.